A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults
Clinical trial NCT06101173 · COMPLETED
Trial details
- NCT number
- NCT06101173
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2024-03-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.